AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Whole cell-based vaccine against pancreatic cancer

Summary

This technology is a whole cell-based vaccine that boosts the patient’s immune system for a precision approach to pancreatic cancer treatment.

Technology Benefits

Greater potential for effectiveness than chemotherapyPatient-specific therapyCombinatorial design (i.e. dendritic cells, macrophages, whole cancer cells) activates complementary immune-response pathways against a full range of pancreatic cancer antibodiesLimits ability of cancer mutation to circumvent treatment

Technology Application

Vaccine for pancreatic cancerVaccine for other cancers with similar cell dynamicsFurther research into immune-cell response and whole-cell based immune-cell engineeringLibrary of various genotypes of immune cells presenting antigens from various whole cancer cellsCombination therapy for cancer in conjunction with chemotherapy and radiation

Detailed Technology Description

None

Country/Region

USA

For more information, please click Here